Glenmark Pharmaceuticals has reported results for the second quarter ended September 30, 2026 (Q2FY27).
The company has reported net profit at Rs 434.89 crore for the quarter ended September 30, 2026 as compared to net loss of Rs 739.19 crore for the same quarter in the previous year. The total income of the company has increased by 41.63% at Rs 2,584.01 crore for Q2FY27 as compared to Rs 1,824.42 crore for the corresponding quarter of the previous year.
On consolidated basis, the company has reported 56.78% fall in its net profit at Rs 263.78 crore for the quarter ended September 30, 2026 as compared to Rs 610.35 crore for the same quarter in the previous year. The total income of the company decreased by 31.97% at Rs 4,249.87 crore for Q2FY27 as compared to Rs 6,247.50 crore for the corresponding quarter previous year.